N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia

Clinical trial NCT00843921 · UNKNOWN

Trial details

NCT number: NCT00843921
Sponsor: Mendel Tuchman
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Inborn Errors of Metabolism

Start date: 2008-08-01
Primary completion: 2018-04-25
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.